Gabapentin Capsule
Product Images NDC 71335-1997

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gaba-fig-1-jpg.jpg (Gaba Fig 1 Jpg)

This is a chart showing the mean pain score over a period of 4 weeks, divided into a dose titration period and a fixed dose period. The chart includes data for a placebo group and a group taking Gabapentin at a dosage of 3600 mg/day. The pain scores range from 0 to 10 and are plotted over a period of 4 weeks. No other information or context is available.*

FDA Label Image

Gaba-fig-2-jpg.jpg (Gaba Fig 2 Jpg)

This text describes a medical study with a 4-week dose titration period followed by a fixed dose period, comparing the effect of two different doses of gabapentin (1800mg/day and 2400mg/day) versus a placebo on pain scores over a six-week period. The results are presented in a table showing mean pain scores at baseline and weeks 1 through 5.*

FDA Label Image

Gaba-fig-3-jpg.jpg (Gaba Fig 3 Jpg)

This appears to be a figure from a study on the effectiveness of different treatments for post-herpetic neuralgia (PHN). The figure shows the proportion of responders (patients with >50% reduction in pain score) at endpoint for controlled PHN studies. The treatments shown include Gabapentin 3600 and 1800, and a placebo. The figure also includes p-values for statistical significance.*

FDA Label Image

Gaba-fig-4-jpg.jpg (Gaba Fig 4 Jpg)

FDA Label Image

Gaba-structure.jpg (Gaba Structure)

FDA Label Image

Gabapentin-formula-jpg.jpg (Gabapentin Formula Jpg)

FDA Label Image

Label (Lbl713351997)

Gabapentin Capsules containing 300mg of Gabapentin, USP. Keep out of reach of children and store at 20-25°C. May cause dizziness. This drug is available by prescription only and comes in a pack of 30 capsules. NDC number is 71335-1997-01.*

FDA Label Image

Label (Lbl7133519972)

This is a prescription medicine packaging information that includes the name of the medicine (Neurontin 300mg Capsule), the manufacturer (Granules India Limited), the quantity (#30 EXP MM/YY), the NDC number (7133519971), and the recommended storage conditions (store at room temp of 20°-25°C or 68°-77°F). It also includes a cautionary statement to keep all drugs out of the reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.